Virion Therapeutics, LLC, a clinical-stage biotechnology company, developing novel T cell-based immunotherapies that utilize checkpoint modifiers, today announced at AASLD's The Liver Meeting (R) , in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback